Angiosarcoma: Clinical Trials

2 trials for Angiosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Angiosarcoma: new trials by email Literature Review of Angiosarcoma trials Research Report on Angiosarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Agnostic Therapy in Rare Solid Tumors
Nivolumab - Urachal Cancer, Parathyroid Carcinoma
Phase 2Active not recruitingInstituto do Cancer do Estado de São Paulo282024-07-162026-10-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17

Narrower conditions

Carcinoma, Adenoid Cystic (2)  ·  Carcinosarcoma (2)  ·  Cholangiocarcinoma (2)  ·  Gallbladder Neoplasms (2)  ·  Hemangiosarcoma (2)  ·  Neurofibrosarcoma (2)  ·  Parathyroid Neoplasms (2)  ·  Thyroid Neoplasms (2)  ·  Vulvar Neoplasms (2)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenal Gland Neoplasms (1)  ·  Adrenocortical Carcinoma (1)  ·  Anus Neoplasms (1)  ·  Bile Duct Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Adnexal Diseases (2)  ·  Adrenal Gland Diseases (2)  ·  Biliary Tract Diseases (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gallbladder Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genital Diseases (2)

Interventions

Nivolumab (2)  ·  CTLA-4 Antigen (1)  ·  Ipilimumab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)

Sponsors

Instituto do Cancer do Estado de São Paulo (1)  ·  National Cancer Institute (NCI) (1)

Countries

Brazil (1)  ·  Guam (1)  ·  United States (1)

Top investigators

Camila MV Moniz, Doctor (1)  ·  Sandip P Patel (1)

Results publications

PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA180888 (1)